USANA Health Sciences (NYSE:USNA) Cut to “Hold” at Sidoti

USANA Health Sciences (NYSE:USNA) was downgraded by equities researchers at Sidoti from a “strong-buy” rating to a “hold” rating in a research note issued on Tuesday,Zacks.com reports.

A number of other equities analysts have also commented on the stock. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. DA Davidson lifted their target price on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research report on Thursday, January 2nd.

USANA Health Sciences Trading Down 0.8 %

NYSE USNA opened at $31.16 on Tuesday. The stock has a market cap of $593.99 million, a PE ratio of 11.01, a PEG ratio of 0.85 and a beta of 0.87. USANA Health Sciences has a 12 month low of $30.13 and a 12 month high of $50.32. The company’s 50-day moving average price is $34.02 and its 200-day moving average price is $36.85.

Institutional Investors Weigh In On USANA Health Sciences

Large investors have recently modified their holdings of the business. Pzena Investment Management LLC boosted its stake in shares of USANA Health Sciences by 3.6% during the fourth quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company’s stock valued at $39,015,000 after purchasing an additional 37,466 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock worth $27,751,000 after buying an additional 55,059 shares during the period. Pacer Advisors Inc. boosted its position in USANA Health Sciences by 8.8% during the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company’s stock valued at $21,247,000 after acquiring an additional 47,745 shares in the last quarter. State Street Corp increased its holdings in shares of USANA Health Sciences by 0.6% in the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock valued at $16,501,000 after acquiring an additional 2,782 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of USANA Health Sciences by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 301,949 shares of the company’s stock worth $10,839,000 after acquiring an additional 4,829 shares in the last quarter. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.